MRA Therapy in Heart Failure: Understanding Endocrine Side Effects
ABSTRACT:
CLINICAL CONTEXT
MRA Therapy in Heart Failure: Understanding Endocrine Side Effects
This expert-led session explores a practical question in heart failure with reduced ejection fraction. It is designed to support a structured clinical discussion around evidence-based care, patient status and appropriate follow-up.
The video should be interpreted alongside current guidelines, local protocols and the individual circumstances of each patient.
SYNOPSIS
“
A focused discussion of endocrine tolerability considerations in MRA therapy.
FEATURED SPEAKER
Prof. Giuseppe Rosano
Consultant Cardiologist and Professor of Cardiology, St George’s, University of London, United Kingdom
IN THIS VIDEO
Key clinical perspectives
- Recognising tolerability concerns
- Understanding treatment differences
- Supporting informed follow-up
This video is intended for healthcare professionals and supports clinical education. It does not replace individual clinical judgement or local guidance.
